Our Technology | Our People | Contact Us









IMMvention is developing next-generation adjuvant formulations which effectively deliver cancer immunotherapy and enhance the efficacy of vaccines.

With our core platform technology, challenging adjuvants are encapsulated at near perfect efficiencies into a premiere polymeric vehicle for triggered intracellular delivery to immune cells. Unlike other technologies, our systems are formulated via scalable and highly efficient processes.

We have established the reproducibility, stability, bioactivity, safety, and efficacy of these formulations in various biological models, including infectious disease and cancer applications. The promising data generated in these preclinical models has laid the groundwork for a robust platform for intracellular drug delivery with significant manufacturing and efficacy advantages.

Contact Webmaster